FindMyRecallSubscribe
Class I: serious health riskTerminated

Zydus Pharmaceuticals (USA) Acyclovir Sodium Injection 500mg/10mL Recall

Acyclovir Sodium Injection 500mg/10mL (50mg/mL) vial NDC 68382-048-01, For Intravenous…

Zydus Pharmaceuticals (USA) Inc · Pennington, NJ

Risk level
Class I
Reported by FDA
Apr 7, 2021
Recall ID
D-0316-2021
Check your lot numberHow we source this data

Summary

Zydus Pharmaceuticals (USA) recalled Acyclovir Sodium Injection 500mg/10mL starting Feb 18, 2021. The FDA classified it as Class I (serious health risk) and published enforcement report D-0316-2021 on Apr 7, 2021. Reason: Crystallization: customer complaints for crystallization in finished product. Status: Terminated.

Why it was recalled

Crystallization: customer complaints for crystallization in finished product.

Product description

Acyclovir Sodium Injection 500mg/10mL (50mg/mL) vial NDC 68382-048-01, For Intravenous Infusion Only MUST BE DILUTED PRIOR TO USE, packaged in 10 x 10mL Single-Dose Vials per pack NDC 68382-048-10, Rx only, Manufactured by: Cadila Healthcare Ltd., Vadodara, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534.

Lot numbers, UPCs & expiration codes

Lot#: L000126, L000127, Exp 12/31/2021

Where it was sold

USA Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0316-2021
Classification
Class I
Status
Terminated
Recall initiated
Feb 18, 2021
FDA report date
Apr 7, 2021
Quantity
1,638 packs
Recall type
Voluntary: Firm initiated
Recalling firm
Zydus Pharmaceuticals (USA) Inc

Original FDA data

Every field from FDA enforcement report D-0316-2021, exactly as published.

Show all FDA fields
City
Pennington
State
NJ
Status
Terminated
Country
United States
Event ID
87364
Address
73 Route 31 N
Code information
Lot#: L000126, L000127, Exp 12/31/2021
Postal code
08534-3601
Report date
Apr 7, 2021
Product type
Drugs
Recall number
D-0316-2021
Classification
Class I
Recalling firm
Zydus Pharmaceuticals (USA) Inc
Product quantity
1,638 packs
Termination date
Nov 23, 2022
Reason for recall
Crystallization: customer complaints for crystallization in finished product.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Acyclovir Sodium Injection 500mg/10mL (50mg/mL) vial NDC 68382-048-01, For Intravenous Infusion Only MUST BE DILUTED PRIOR TO USE, packaged in 10 x 10mL Single-Dose Vials per pack NDC 68382-048-10, Rx only, Manufactured by: Cadila Healthcare Ltd., Vadodara, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534.
Distribution pattern
USA Nationwide
Recall initiation date
Feb 18, 2021
Initial firm notification
Letter
Center classification date
Mar 30, 2021

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0316-2021, published Apr 7, 2021. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls